25.34
前日終値:
$25.40
開ける:
$25.56
24時間の取引高:
7,075
Relative Volume:
0.28
時価総額:
$N/A
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+3.39%
1か月 パフォーマンス:
+4.54%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
OZEM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
OZEM
Roundhill Glp 1 Weight Loss Etf
|
25.34 | 0 | 0 | 0 | 0 | 0.00 |
![]()
VTI
Vanguard Total Stock Market Etf
|
298.00 | 417.53B | 0 | 0 | 0 | 0.00 |
![]()
SPY
Spdr S P 500 Etf Trust
|
600.77 | 372.57B | 0 | 0 | 0 | 0.00 |
![]()
IVV
Ishares Core S P 500 Etf
|
603.80 | 253.41B | 0 | 0 | 0 | 0.00 |
![]()
VB
Vanguard Small Cap Etf
|
247.71 | 160.59B | 0 | 0 | 0 | 0.00 |
![]()
QQQ
Invesco Qqq Trust Series 1
|
522.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf (OZEM) 最新ニュース
Slower flows, small-cap woes, SEC nos! What to expect from ETFs in 2025 - Citywire Professional Buyer
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Roundhill Investments Surpasses $4 Billion AUM Milestone – Company Announcement - Financial Times
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Eli Lilly Lowers Q4 Sales Outlook: Best ETFs to Consider Now - espeaks.co.uk
ROUNDHILL -- A "Roundhill Roundup" -- all Roundhill Investments products since inception - substack.com
Jane Street Group LLC Has $1.16 Million Stock Position in Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Defense World
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares - Benzinga
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times
Mag7, AI and GLP-1: Roundhill CEO on the hottest ETFs to watch - CNBC
Disruptive Theme of the Week: Playing Defense - ETFdb.com
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - Yahoo Finance
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs? - Yahoo Lifestyle UK
Weight loss drug may cut heart failure risk, company says - Yahoo News Australia
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials - Yahoo Singapore News
Why Investors Haven't Feasted on Two New Weight-Loss ETFs - Investopedia
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea - Yahoo Canada Shine On
Weight-loss ETFs demand some heavy thinking - Financial Times
Diabetes drug recommended to treat obesity on the NHS - Yahoo News UK
ETFs to Profit from the Weight Loss Drug Boom - Yahoo Finance
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk - Markets Insider
OZEM, Weight Loss Drug ETFs: Should You Invest? - etf.com
Did South Park mark the top for weight-loss stocks? - Sherwood News
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF - InvestorPlace
This new weight loss drug ETF bets big on two of the industry's leading players - CNBC
This Week in ETFs: Roster of 17 New ETFs Includes 6 Buffer Funds - ETF Trends
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next - Benzinga
Play These New ETFs to Tap Lucrative Weight Loss Drug Market - Yahoo Finance
ETFs Targeting Weight-Loss Market Gain Traction - Finimize
Roundhill Investment launches GLP-1 & Weight Loss ETF (NASDAQ:OZEM) - Seeking Alpha
Fund Files: Eaton Vance, Voya PMs to depart; Roundhill launches active weight loss ETF - Citywire Professional Buyer
EXCLUSIVE: GameStop, AMC Buzz 'May Prove To Be Short-Lived,' CEO Of Company Behind MEME ETF Tells Benzinga - Markets Insider
Thematic ETF Winners of the Q1 2024 Earnings Season - ETF Trends
Tori Spelling reveals she tried Ozempic, Mounjaro after birth of fifth child - Yahoo Lifestyle Australia
Roundhill names new CEO - Citywire Professional Buyer
Weight Loss Drugs Zepbound and Mounjaro Are in Shortage Due to 'Demand Increase,' FDA Says - Yahoo News Canada
Two fresh ways to play the weight loss and megacap tech hype - CNBC
Experts hesitate on weight loss ETFs amid the obesity drug boom - CNBC
Roundhill Investments - etf.com
Roundhill Glp 1 Weight Loss Etf (OZEM) 財務データ
Roundhill Glp 1 Weight Loss Etf (OZEM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):